Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,246,148
-$1,439,956 QoQ
Shares Held
236,291
-9.6% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. SRPT ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,246,148 | 236,291 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,686,104 | 261,310 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,680,835 | 217,511 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,187,119 | 217,287 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,883,099 | 461,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,493,872 | 336,789 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $37,816,069 | 311,013 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $39,627,720 | 317,301 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $48,729,254 | 308,413 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,882,214 | 230,822 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $22,276,871 | 231,016 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $91,303,507 | 753,205 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $87,744,420 | 766,193 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $103,268,574 | 749,246 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $77,553,370 | 598,498 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $85,705,308 | 775,333 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,528,968 | 700,760 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $76,782,115 | 982,874 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $98,788,720 | 1,097,043 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $87,250,161 | 943,449 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $86,741,513 | 1,115,790 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $84,986,036 | 1,140,293 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $272,328,960 | 1,597,331 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $217,265,149 | 1,547,142 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $242,393,513 | 1,511,747 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $157,174,240 | 1,606,770 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||